Impact of nuclear cardiac imaging on the present and future practice of cardiology

European Journal of Nuclear Medicine

Volumn 27, Issue 1 SUPPL., 2000, Pages

  Verani, Mario S ^a   Willerson, James T ^b,c,d,e  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c MEMORIAL HERMANN HOSPITAL   (United States)

^d TEXAS HEART INSTITUTE   (United States)

^e ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IODINE 123; MYOSIN ANTIBODY IN 111; NITROGEN 13; OXYGEN 15; PYROPHOSPHATE TECHNETIUM TC 99M; RUBIDIUM 82; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201;

ACUTE HEART INFARCTION; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; HEART DISEASE; HEART INFARCTION SIZE; HEART VENTRICLE FUNCTION; MYOCARDIAL HIBERNATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; SHORT SURVEY; STUNNED HEART MUSCLE;

CARDIOLOGY; CORONARY DISEASE; HEART; HUMANS; PROGNOSIS;

EID: 0033969858     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (46)

1. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grumwald MA, Levy D, Lytle BW, O'Rourke RA, Schafer WP, Williams SV. ACC/AHA/ ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 1999; 99: 2829-2848.
2. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, van Train KF, Berman DS. Automatic quantification of ejection fraction from gated myocardial perfusion SPET. J Nucl Med 1995; 36: 2138-2147.
3. Germano G, Erel J, Kiat H, Kavanagh PB, Berman DS. Quantitative LVEF and qualitative regional function from gated thallium-201 perfusion SPET. J Nucl Med 1997; 38: 749-754.
4. Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1997; 30: 1360-1367.
5. Nichols K, DePuey EG, Rozanski A. Automation of gated tomographic left ventricular ejection fraction. J Nucl Cardiol 1996; 3: 475-482.
6. Berman D, Germano G, Lewin H, Kang X, Kavanagh PB, Tapino P, Harris M, Friedman J. Comparison of post-stress ejection fraction and relative volumes by automatic analysis of gated myocardial perfusion single-photon emission computed tomography acquired in supine and prone positions. J Nucl Cardiol 1998; 5: 40-47.
7. Vaduganathan P, He ZX, Vick GW, Mahmarian JJ, Verani MS. Evaluation of left ventricular wall motion, volumes and ejection fraction by gated myocardial tomography with Tc-99m tetrofosmin: a comparison with cine magnetic resonance imaging. J Nucl Cardiol 1999; 6: 3-10.
8. He ZX, Cwajg E, Preslar JS, Mahmarian JJ, Verani MS. Accuracy of left ventricular ejection fraction determined by gated myocardial perfusion SPET with thallium-201 and technetium-99m sestamibi: comparison with first-pass radionuclide angiography. J Nucl Cardiol 1999; 6: 412-417.
9. Williams KA, Taillon LA. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images. Comparison with assessment by contrast ventriculography and first-pass radionuclide angiography. J Am Coll Cardiol 1996; 27: 173-181.
10. Cwajg E, Cwajg J, He ZX, Hwang WS, Keng F, Nagueh SF, Verani MS. Gated myocardial perfusion tomography for the assessment of left ventricular function and volumes: comparison with echocardiography. J Nucl Med 1999; (in press).
11. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of T1-201 and Tc-99m sestamibi SPET imaging (perfusion and ECG-gated SPET) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29: 69-77.
12. Iskandrian AS, Verani MS. Nuclear cardiac imaging. Principles and applications. Philadelphia: F.A. Davis; 1996: pp 110-118.
13. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA. Exercise myocardial perfusion SPET in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905-911.
14. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation 1991; 83; 363-381.
15. 99mTc-sestamibi single-photon emission computed tomography. Circulation 1996; 93: 463-473.
16. He ZX, Scarlett MD, Mahmarian JJ, Verani MS. Enhanced accuracy of defect detection by myocardial single-photon emission computed tomography with attenuation correction with gadolinium-153 line sources: evaluation with a cardiac phantom. J Nucl Cardiol 1997; 4: 202-210.
17. Hendel RC, Berman DS, Cullom SJ, Follansbee W, Heller GV, Kiat H, Groch MW, Mahmarian JJ. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPET myocardial perfusion imaging. Circulation 1999; 99: 2742-2749.
18. Verani MS, Mahmarian JJ, Hixson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990 82: 80-87.
19. Leppo JA. Dipyridamole-thallium imaging: the lazy man's stress test. J Nucl Med 1989; 30: 281-287.
20. Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993; 21: 1583-1590.
21. 99mTc-stannous pyrophosphate myocardial scintigrams clinically useful? Clin Nucl Med 1977; 2: 137.
22. Lewis SE, Devous MD Sr, Corbett JR, et al. Measurement of infarct size in acute canine myocardial infarction by single-photon emission computed tomography with technetium-99m pyrophosphate. Am J Cardiol 1984; 54: 193-199.
23. Khaw BA, Gold HK, Yasuda T, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation 1986; 74: 501-508.
24. Johnson LL, Lerrick KS, Coromilas J, et al. Measurement of infarct size and percent myocardium infarcted in a dog preparation with single photon-emission computed tomography, thallium-201, and indium 111-monoclonal antimyosin Fab. Circulation 1987; 76: 181-190.
25. Perez-Gonzalez J, Botvinick EH, Dunn R, et al. The late prognostic value of acute scintigraphic measurement of myocardial infarction size. Circulation 1982; 66: 960-971.
26. 99mTc-pyrophosphate. Circulation 1978; 57: 320-326.
27. Gibbons RJ, Verani MS, Behrenbeck T, et al. Feasibility of tomographic technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of acute treatment in myocardial infarction. Circulation 1989; 80: 1277-1286.
28. Gibbons RJ, Holmes DR, Reeder GS, et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685-691.
29. Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992; 86: 81-90.
30. Wackers FJT, Lie KL, Liem KL, et al. Thallium-201 scintigraphy in unstable angina pectoris. Circulation 1978; 57: 738-742.
31. Verani MS, Jeroudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988; 12: 1573-1581.
32. Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ, Beller GA. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigrapy and coronary angiography. Circulation 1983; 68: 321-336.
33. Dakik HA, Mahmarian JJ, Kimball KT, Coutelou MG, Medrano R, Verani MS. Prognostic value of thallium-201 tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation 1996; 94: 2735-2742.
34. Leppo JA, O'Brien J, Rothendler JA, et al. Dipyridamole thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984; 310: 1014-1018.
35. Brown KA, O'Meara J, Chambers CE, et al. Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Am J Cardiol 1990: 65: 160-167.
36. Mahmarian JJ, Pratt CM, Nishimura S, et al. Quantitative adenosine thallium-201 single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction. Circulation 1993; 87: 1197-1210.
37. Mahmarian JJ, Mahmarian AC, Marks GF, et al. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol 1995; 25: 1333-1340.
38. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1996; 94: 2341-2350.
39. van Royen N, Jaffe CC, Krumholz HM, Johnson KM, Lynch PJ, Natale D, Atkinson P, Deman P, Wackers FJ. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol 1996; 77: 843-850.
40. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96: 793-800.
41. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30: 1451-1460.
42. He ZX, Verani MS. Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used? J Nucl Cardiol 1998; 5: 527-532.
43. Glover DK, Ruiz M, Yang JY, Koplan BA, Allen TR, Smith WH, Watson DD, Barrett RJ, Beller GA. Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist. Circulation 1996; 94: 1726-1732.
44. 2a receptor agonist. (Submitted for publication, 1999).
45. Dewanjee MK, Nezam H, Narula J. Imaging with radiolabeled antisense oligonucleotides for the detection of intracellular messenger RNA and cardiovascular disease. J Nucl Cardiol 1999; 6: 345-356.
46. Weber DA, Ivanovic M. Ultra-high resolution imaging of small animals: implications for preclinical and research studies. J Nucl Cardiol 1999; 6: 332-344.